Recent Finacing
Recent Raise
Anoat Therapeutics is a Paris-based preclinical biotechnology company developing antisense oligonucleotide therapies that target alternative chloride channels to restore ion transport in cystic fibrosis and rare diseases.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor